cannabis investing 101 - medical marijuana, inc. · 2017-09-25 · medical marijuana inc. provides...

Cannabis Investing 101

2The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred.

Stuart W Titus Background Wall Street

• Bond Trader & Underwriter for Credit Suisse First Boston Corp


President & CEO Medical Marijuana Inc.

• OTC Public Company; Ticker Symbol: MJNA


Topic: Cannabis Investing 101

5

ALL Investment Decisions Involve RISK

• Doing Nothing is a Decision

• Putting Money Under Your Mattress is a Risk

• US Government Securities Are Rated AA+ by S&P

• Banks – 2008 / 2009 Financial Crisis

• Stocks – Like Going to Las Vegas if You’re Not a Wall Street Insider

The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred.

6

Ideal Portfolios Are Diversified

• Conservative Investments Coupled with

• More Speculative Investments aka The Barbell Strategy



• A $5,000 Investment in AAPL IPO in 1980

• Is Worth Over $1,200,000 Today

• Link: http://www.1stock1.com/1stock1_1764.htm

Some Companies in This Space Will be the Next Apple Computer

Most Cannabis Investments, at this stage, Are Speculative


Stocks Are Cyclical

• Stocks Fall into Categories Which Fall into & Out of Investor Favor aka “Institutional Rotation” / Portfolio Management

• Stocks Compete with Other Alternative Investments: Bonds / Fixed Income Markets

• Stock Groups: Industrials Bio-Techs Airlines & Transportation Utilities Financials, etc.

• And Now the Cannabis Sector• Was “In Favor” First Half 2014• Currently “Out of Favor” Relatively• Many Companies with Promise but Need Federal Legalization to Realize Their Full Potential


Cannabis Stocks Can Be Volatile

• CannaVest Corp – Public in Nov 2012 under FCLS

• Name Change Early 2013, Value $1.50 per Share; New Symbol was CANV

• Some Trading Dec 2013 around $15 a share

• CANV: Assets Purchased, Developed Hemp-CBD Pipeline from Europe

• By July 2014 Up to $200+ a Share, Huge Trading Volume

• Market Capitalization $6.5 Billion at Peak

• Today Share Price 37 Cents, Management Failure, Broken Contracts, etc.

• Now Trades Under CVSI


CannaVest stock prices 2013-2016


Investing:

• Experienced Professionals with Track Records

• Steve D’Angelo / Troy Dayton – Harborside Dispensary 125,000 Patients

• San Jose Location ~ 40,000 Patients

• Peter Thiel – Silicone Valley Investor Entering The Cannabis Space

• Visionary Leader with Well Proven Track Record

Sometimes One Bets on “The Horse”; Other Times Bet on “The Jockey”


Scotts Miracle Grow (NYSE: SMG) to Invest $500 Million in Cannabis

• Scotts Miracle Grow (NYSE: SMG) to Invest $500 Million in Cannabis

• Generally, Somewhat Toxic, Non-Eco- Friendly Grow Nutrients

• No Cannabis Grower Would “Trust” SMG in Present Form

• Nonetheless SMG CEO Sees the Potential for this Industry

• CEO: Jim Hagendorn

• Link: http://www.thecannabist.co/2016/07/06/scotts-miracle- gro-ceo- marijuana-investment-gmo/57684/


Cannabis Stocks – Investment Opportunities in Cannabis Businesses:

• Dispensaries• Dispensary Construction• Grow & Cultivation Operations• Soil Nutrients• Grow Lights, Fans• Greenhouses• Warehouses, Land, Landlord / Tennant Businesses• HVAC• Security Companies• Infused Products – 70% of Colorado Marketplace• Delivery Services• Botanists / Seed Genetics / R&D• Education• Pharmaceutical Development• Nutraceutical Companies• Hemp Food Products• Testing Labs• Extraction Companies & Equipment Providers• Cannabis Packaging• Vape / Vaporizers• Product Formulators• Solar or Other Natural Power Sources – Indoor Grows Use Lots of Power


Now Cannabis Investment Funds Are Emerging

• Diversified Portfolios of Many Companies

• Theory – Some Will Be HUGE Winners


Cannabis Also Includes Hemp:

• Hemp Seed and Hemp Food Companies Have Done Exceptionally Well• The US Consumes $600 Million + of Hemp Products Annually (HIA)

• Hemp Food Products Companies



• Manitoba Harvest, a Hemp Seed, Hemp Oil, Protein Powder Co from Canada Bought by US Compass Diversified for $132.5 Million in Summer 2014 Compass (OTC: CODI) Purchased an 87% Ownership Stake The Transaction was at a Price Equal to 3.5 Times Annual Sales Manitoba Harvest Has Been a Leader in the Branded Hemp Food Markets



• Summer of 2015, Manitoba Harvest & CODI Purchase Hemp Oil Canada Purchase Price was $42 Million Hemp Oil Canada is also a Producer of Hemp Seed, Oil & Protein Powder Here, They Were Leaders in the Hemp Ingredient Market HOC Had Revenue of $18 Million in 2014 Transaction Was for 2.2 Times Annual Sales “Ingredients Margins” Are Thinner Than for retail Branded Products

• The Combined Enterprise Should Have Annual Revenue of $75 Million

• re Scotts Miracle Grow, last sentence: Recently SMG has been trading over $90, close to the all time high of $96.



• Hemp Food Products Are in 3% of Canadian Households Hemp Food Products Are in Less Than 1% of US Households Both Enterprises Believe There is Plenty of Room to Grow HOC Had 400 Customers Purchasing Hemp Ingredients Hemp Seed Oil, Hulled Hemp Seeds, Hemp Protein Hemp Flour and Hemp Coffee Manitoba Harvest Ships Branded Hemp Hearts, Hemp Bars Hemp Protein to 7,000 Stores in Canada & USA Link: http://www.winnipegfreepress.com/business/hemp-firms-fire-up-42- m-merger-362590521.html


Pharma Development Opportunities


Cannabis As A Medicine

• Cannabis has been used as a medicine since the beginning of recorded history. The Marihuana Tax Act of 1937 and the subsequent removal from the US Pharmacopoeia in 1942 have effectively ended any medicinal usage for cannabis.


Cannabis As A Medicine

• Pharmaceutical Development Continues Despite Cannabis Prohibition

• Cesamet was apporived in 1985 to treat post chemotherapy pain, nausea and vomiting. This is a synthetic THC compound that has received a Federal Schedule 2 approval.

• Marinol / Dronabinol - again synthetic THC compounds - were subsequently developed as similar medications with similar indications and approved as Schedule 2 and 3 respectively.

• Marinol / Dronabinol have also been approved for Loss of Appetite in AIDS patients


CBD Research

• Epilepsy

• Metabolic Syndrome

• Broken bones

• Osteoporosis

• Parkinson’s

• Alzheimer’s

• Anti-Cancer

• Neuro-Protection / Traumatic Brain Injury


Pharmaceutical Development Opportunities

• Pharma Leader: GW Pharmaceuticals, Based in London

• (US OTC: GWPH)

• Lead Product is Sativex Oral Spray for Pain & Muscular

• Spasticity Indications

• Approved in Numerous European Countries & Canada



• Second Product, Epidiolex, is Nearing US FDA Approval for Epilepsy

• Latest Results Showed a 44% Reduction in Seizures in LGS Children

• Stock Trades ~ $90 a Share in US and Nearly $2 Billion Market Cap

• Significant Research on Cannabinoids in Israel

• Many Smaller US Companies Are Partnering w Israeli Firms

• One Could Be the Next GWPH


Other Pharma Development Companies

• INSYS Therapeutics: NASDAQ: INSY Pharmaceutical Grade CBD for Epilepsy Oral Dronabinol for Post Chemotherapy Nausea & Vomiting

• Zynerba Pharma: NASDAQ: ZYNE Developing a topical application synthetic CBD for various indications

• OWC Pharma: OTC: OWCP Developing cannabis based therapeutics for Fibromyalgia, Migraine, PTSD, etc

• Kalytera Pharma: Private Developing cannabis-like compounds for osteoporosis and other bone loss indications

• Many others are entering the space...



• MJNA Has Two Pharma Development Companies We Are “Incubating” AXIM Biotech (OTC: AXIM) Medicated Chewing Gum MedChew – 50% THC and 50% CBD Pain Indications in Europe Topical Application CBD / CBG for Psoriasis / Atopic Dermatitis Kannalife Sciences Inc. (still private) KSI Holds 2 License Agreements with US NIH (via OTT Commercialize US Patent #6,630,507 Indications HE and CTE


Vaporized Products

• A Huge Market Developed for Vaporized Cannabis

• E-Cigarettes Are Hugely Popular Amongst Young Adults

• BMJ Research Shows E-Cigs 95% Less Toxic Than Smoked Cigarettes

• Syqe Medical from Israel Received $20 Million from Altera / Phillip Morris

• Special Vaporizer with Dose Meter for Cannabis

• Link: http://www.reuters.com/article/pmi-israel- idUSL8N153292


Ancillary Businesses & Investing Opportunities

• Delivery Service Ease has a mobile app where San Franciscans can search for a local Dispensary, order product and have cannabis and related goods delivered within 20 minutes. The catch is it is cash-only.

• Consulting service MedMen assists companies with licensing and management. Starting out with California, MedMen has expanded services into Nevada and Illinois markets. The company has recently partnered with PharmaLabs, a Cannabis-Cup winning maker of edibles and oils. Medmen recently raised $3.75 million to launch operations in Nevada and Illinois.

• Cannabis excursions and lodging facilities group, Get High Getaway is a B&B run by a husband and wife duo. At this Denver locale, smoking cannabis is encouraged and along with your room, one gets access to a personal driver, available 24/7.


Ancillary Businesses & Investing Opportunities Part II

• Terratech (US OTC: TRTC) – a cannabis focused agricultural company with a Dispensary model. Their hydroponic systems have achieved a 30% increase in annual agricultural crop yields and upwards of a 50% decrease in operating costs. This provides upwards of a 50% increase in gross margins.

• In Alma, Colorado, a floral group known as Buds and Blossoms provides wedding flowers as well as specialty bud for that special occasion. Owner, Bec Koop merged her traditional floral arrangement business with her passion for marijuana.

• As more industry-wide regulation sets is, child resistant plastic storage bags need to meet government standards. Sack makes childproof opaque bags that conform to state regulations – so one can walk out of a Dispensary with a locked plastic bag in accordance with state laws.

• Kalytera Pharma: newly public on the TSE under KALY


Ancillary Businesses & Investing Opportunities Part III

• CannaBuild offers a digital bud-tender service that allows for information regarding different strains, potency and other characteristics to help Colorado patients pick their ideal combination of herbal cannabis.

• Sensimilla social network allows people to be anonymous, yet provides a platform for cannabis-related activities that will not get back to employers, families, etc. Termed “the Instagram for tokers”, this service has over 100,000 users.

• Leafy, a Seattle-based company owned by Privateer Holdings, has a mobile app that is an on-line community for cannabis enthusiasts. One can explore and rate various strains, review dispensaries and keep up with industry news via this app. Privateer also owns Tilray, a Canadian licensed marijuana producer.


Ancillary Businesses & Investing Opportunities Part IV

• Tweed, Canopy Growth Corp – public company in Canada (Vancouver Exchange: CGC.V or US OTC: TWMJF). Licensed producer within the Canadian Medical Marijuana system, earlier this year raised $10 million of investor funds.

• Dixie Elixirs – a private company focused on the developing of infused products, holds the first infused-products license within Colorado. Now expanding to other medical cannabis-friendly states, Dixie was the first into the Colorado infused marketplace, which today – infused products represent about 70% of the entire Colorado cannabis market (nearly $1 billion in 2015).

• Growlife (US OTC: PHOT) is a provider of farming soil, hydroponics equipment organic plant nutrients and other ancillary-to-grow products and services. The company sells through e-commerce via Greners.com as well as via traditional storefront retailers. Back in mid-2014 the company shares experienced a large run-up from near 1 cent to over 50 cents a share. Today, trading values company shares back around 1 penny.


My Observations:

• EVERYTHING IN THIS INDUSTRY IS GROUND FLOOR – EVERYTHING

• Imagine Buying Seagrams, Jim Beam, Anheuser-Busch Before the End of Prohibition

• Cannabis and Cannabinoids Support The LARGEST SELF REGULATORY SYSTEM WITHIN THE HUMAN BODY – The Endogenous Cannabinoid System

• Great Things Happen to People’s Health & Wellness When They Become Users

• Non-psychoactive CBD is Now Readily Available


My Observations:

• One Can Be Cannabinoid Deficient (CEDS) Which Leads to Many Difficult to Treat Medical Conditions, Including: Fibromyalgia Chronic Fatigue Migraine Headache Irritable Bowel Syndrome, Etc. NIH Link: http://www.ncbi.nlm.nih.gov/pubmed/15159679 Study Conclusion:

• Migraine, fibromyalgia, IBS and related conditions display common clinical, biochemical and pathophysiological patterns that suggest an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines. Plant based Cannabinoids Can Also Supplement


My Observations:

• US Government Research Classified Cannabinoids as: Anti-Oxidants & Neuroprotectants. Link: http://www.google.com/patents/US6630507 Showing Benefit for Metabolic Syndrome Patients, Including Heart Cardiovascular Diabetes Rheumatoid Arthritis Via Decreased Inflammation

• CBIS - Cannabis Science Was below 1 cent as recently as Sept 21 2016 Now 3.22 cents as of Oct 17th 2016 Now at 12 cents as of Feb 8 2018 CEO Dr Robert Melameade

• OWCP - OWC Pharmaceuticals Was 2 cents for most of 2016, dropped to 0.5 cents on Sept 27 2016 Now 5.31 cents as of close on Oct 17 2016 Working on an orphan drug for bone-related disorders with cannabinoids partnered with Israeli research groups


My Observations:• Showing Benefit for Neurological Conditions

Alzheimer’s Parkinson’s, etc

• Parkinson’s & Alzheimer’s Are Well On The Rise Every 10 Calendar years of Life Shows 24% Greater Risk

• Opportunities to Assist People and Decrease Overall Health Expenditures

• GWPH PO May 2014 at $10 a share Traded as low as $81 on Aug 30 2016 Ran up to over $130 on early October 2016 $127 on Oct 17 2016 Currently $129 as of Feb 2017

• Products: Sativex - approved... Epidiolex - working...

• INSY - Insys Therapeutics Traded up to $44 during summer 2015 Closed at $10.88 on Oct 17 2016 Working... Oral Dronabinol... Many other...


Conclusion:

• CANNABIS – THE NEXT GREAT GROWTH INDUSTRY IN AMERICA & WORLD Marijuana – Pain Relieving Benefits States with Medical Cannabis Laws Show 25% Fewer OD Deaths from Opioids Overall Cost to Medicare Was Down $165 Million in 2013 (13 States) If Nationalized, This Would Be $500 Million ($1/2 Billion)

• ZYNE - Zynerba IPO at $13 Ran up to $33 just after their IPO Aug 2015 Low of $6 in May 2016 $11.27 on Oct 17 2016 $18.82 as of Feb 8 2017 Working...

• TRTC - Terra Tech Near 10 cents a share in Feb 2016 Close on Oct 17 2016 at 42 cents per share Currently at 31 cents on Feb 8 2017 Hydroponics...


Conclusion:

• Hemp – CBD, Non-psychoactive but Numerous Medicinal Benefits 50,000+ Industrial Uses – Present Significant Investment Opportunities France Builds 1,000+ Hemp Homes Annually German Auto Makers Mercedes Benz and BMW Use Hemp for: Auto Parts Including Door Panels, Dashboards These are Hemp Bio-Plastics Soon to Replace All Oil Based Water Bottles

• CBDS: $6.12 as of Feb 8 2017

• MJNA: 15 cents as of Feb 8 2017


Conclusion:

• Bio-Mass for Bio-Fuel Hemp Textiles – Non-Toxic to the Environment Cotton Uses 12% of all World Agro-Chemicals Hemp Foods – Super Foods Packed with Nutrition Hemp Batteries & Ultra-Capacitors for Energy Storage


Conclusion:

• Good Luck to All Investors…!

cannabis investing 101 - medical marijuana, inc. · 2017-09-25 · medical marijuana inc. provides...

Documents